Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

A new beginning: Adverse drug reaction manager a way of increasing the number of spontaneous reporting

Dalhoff, Kima,b; Andersen, Jon Trærupa,b; Andersen, Jon Trærupa,b; Jimenez-Solem, Espena,b; Dalhoff, Kim Pedera,b

doi: 10.1097/FAD.0000000000000035
Editorial

aDepartment of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg

bInstitute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

aDepartment of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg

bInstitute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Correspondence to Kim Dalhoff, MD, DMSc, FEAPCCT, Professor of Clinical Pharmacology (Clinical Toxicology), Department of Clinical Pharmacology, Bispebjerg and Frederiksberg University Hospital, Frederiksberg, 2400 Copenhagen, Denmark. Tel: +45 3863 5101; Mobile: (45) 2825 4783; e-mail: kim.peder.dalhoff@regionh.dk

Correspondence to Jon Trærup Andersen, MD, PhD, Associate Professor of Clinical Pharmacology, Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, DK-2400 Copenhagen, Denmark. Tel: +45 3863 5726; e-mail: jon.thor.traerup.traerup.andersen@regionh.dk

Editor: Kim Peder Dalhoff, MD, DMSc, FEAPCCT, Professor of Clinical Pharmacology, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg University Hospital, Frederiksberg, 2400 Copenhagen, Denmark. Associate Editor: Jon Trærup Andersen, MD, PhD. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield; England: Dr J K Aronson, Dr A Hitchings; India: Professor N Gogtay; Ireland: Dr J Feely; Netherlands: Professor C J van Boxtel, B H Ch Stricker; Sweden: Dr S Hagg; Wales: Professor P A Routledge.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.